These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22951019)

  • 1. Bioenergetic gain of citrate anticoagulated continuous hemodiafiltration--a comparison between 2 citrate modalities and unfractionated heparin.
    Balik M; Zakharchenko M; Leden P; Otahal M; Hruby J; Polak F; Rusinova K; Stach Z; Tokarik M; Vavrova J; Jabor A; Oudemans-van Straaten HM
    J Crit Care; 2013 Feb; 28(1):87-95. PubMed ID: 22951019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.
    Cointault O; Kamar N; Bories P; Lavayssiere L; Angles O; Rostaing L; Genestal M; Durand D
    Nephrol Dial Transplant; 2004 Jan; 19(1):171-8. PubMed ID: 14671053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of systemic delivery of substrates for intermediate metabolism during citrate anticoagulation of continuous renal replacement therapy.
    Balik M; Zakharchenko M; Otahal M; Hruby J; Polak F; Rusinova K; Stach Z; Vavrova J; Jabor A
    Blood Purif; 2012; 33(1-3):80-7. PubMed ID: 22212643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focusing on the basic principles of dialysis to optimize regional citrate anticoagulation.
    Mariano F
    J Crit Care; 2013 Feb; 28(1):99-100. PubMed ID: 23159145
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of a novel calcium-free lactate buffered dialysis and substitution fluid for regional citrate anticoagulation--prospective feasibility study.
    Balik M; Zakharchenko M; Leden P; Otahal M; Rulisek J; Brodska H; Stritesky M
    Blood Purif; 2014; 38(3-4):263-72. PubMed ID: 25591617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate.
    Gupta M; Wadhwa NK; Bukovsky R
    Am J Kidney Dis; 2004 Jan; 43(1):67-73. PubMed ID: 14712429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.
    Morgera S; Haase M; Ruckert M; Krieg H; Kastrup M; Krausch D; Vargas-Hein O; Zuckermann-Becker H; Peters H; Pohlmeier R; Neumayer HH
    Nephron Clin Pract; 2005; 101(4):c211-9. PubMed ID: 16155399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium flux during continuous venovenous haemodiafiltration with heparin and citrate anticoagulation.
    Brain M; Anderson M; Parkes S; Fowler P
    Crit Care Resusc; 2012 Dec; 14(4):274-82. PubMed ID: 23230876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience.
    Morgera S; Scholle C; Voss G; Haase M; Vargas-Hein O; Krausch D; Melzer C; Rosseau S; Zuckermann-Becker H; Neumayer HH
    Nephron Clin Pract; 2004; 97(4):c131-6. PubMed ID: 15331942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A.
    Flanigan MJ; Pillsbury L; Sadewasser G; Lim VS
    Am J Kidney Dis; 1996 Apr; 27(4):519-24. PubMed ID: 8678062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury.
    Durão MS; Monte JC; Batista MC; Oliveira M; Iizuka IJ; Santos BF; Pereira VG; Cendoroglo M; Santos OF
    Crit Care Med; 2008 Nov; 36(11):3024-9. PubMed ID: 18824904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure.
    Morgera S; Scholle C; Melzer C; Slowinski T; Liefeld L; Baumann G; Peters H; Neumayer HH
    Nephron Clin Pract; 2004; 98(1):c35-40. PubMed ID: 15361702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate anticoagulation during post-dilution hemodiafiltration with a high cut-off (Theralite) membrane.
    Kovač J; Gubenšek J; Pernat AM; Buturović-Ponikvar J; Kersnič B; Pretnar J; Ponikvar R
    Ther Apher Dial; 2011 Jun; 15(3):283-6. PubMed ID: 21624077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction.
    De Vico P; Messino V; Tartaglione A; Beccaris C; Buonomo C; Talarico D; Prati P; Sabato AF; Colella DF
    Ther Apher Dial; 2015 Jun; 19(3):272-8. PubMed ID: 25656632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrate-Buffered Dialysis Solution (Citrasate) Allows Avoidance of Anticoagulation During Intermittent Hemodiafiltration-At the Cost of Decreased Performance and Systemic Biocompatibility.
    Richtrova P; Mares J; Kielberger L; Trefil L; Eiselt J; Reischig T
    Artif Organs; 2017 Aug; 41(8):759-766. PubMed ID: 27859427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: the 'Modified Alabama Protocol'.
    Davies H; Morgan D; Leslie G
    Aust Crit Care; 2008 Aug; 21(3):154-65. PubMed ID: 18635373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional citrate anticoagulation during hemodialysis: a simplified procedure using Duocart biofiltration.
    Ridel C; Mercadal L; Béné B; Hamani A; Deray G; Petitclerc T
    Blood Purif; 2005; 23(6):473-80. PubMed ID: 16282684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin versus citrate in continuous haemodiafiltration: an observational study in patients with high risk of bleeding.
    Balik M; Waldauf P; Plásil P; Pachl J
    Blood Purif; 2005; 23(4):325-9. PubMed ID: 16118487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
    Ong SC; Wille KM; Speer R; Tolwani AJ
    Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.